Genistein arrests hepatoma cells at G2/M phase: Involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1

Biochemical Pharmacology

Volumn 67, Issue 4, 2004, Pages 717-726

  Chang, Kee Lung ^a   Kung, Mei Lang ^a   Chow, Nan Haw ^b   Su, Shu Jem ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

Author keywords

ATM; Genistein; HepG2; p21waf1 cip1; p53; Wee1

Indexed keywords

ATM PROTEIN; CAFFEINE; CDC25C PHOSPHATASE; CHECKPOINT KINASE 2; GENISTEIN; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN; PROTEIN KINASE; PROTEIN P21; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; PROTEIN WEE1; UNCLASSIFIED DRUG;

ARTICLE; ATAXIA TELANGIECTASIA MUTATED GENE; CELL CYCLE G2 PHASE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENE; HEPATOMA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 1642575107     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.10.003     Document Type: Article

References (48)

1. Messina M., Barnes S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 83:1991;541-546.
2. Wei H., Bowen R., Cai Q., Barnes S., Wang Y. Antioxidant and anti-promotion effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 208:1995;124-130.
3. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 125:1995;777S-783S.
4. Knight D.C., Eden J.A. A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87:1996;897-904.
5. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 68:1998;1333S-1346S.
6. Lamartiniere C.A., Moore J.B., Brown N.M., Thompson R., Hardin M.J., Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis. 16:1995;2833-2840.
7. L down-regulation, and Cdc2 kinase activity. Nutr. Cancer. 45:2003;113-123.
8. Shao Z.M., Alpaugh M.L., Fontana J.A., Barsky S.H. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J. Cell Biochem. 69:1998;44-54.
9. Su S.J., Yeh T.M., Lei H.Y., Chow N.H. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin. Cancer Res. 6:2000;230-236.
10. McGowan C.H., Russell P. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J. 12:1993;75-85.
11. Booher R.N., Holman P.S., Fattaey A. Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem. 272:1997;22300-22306.
12. Jin P., Gu Y., Morgan D.O. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134:1996;963-970.
13. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 277:1997;1501-1505.
14. Sanchez Y., Wong C., Thoma R.S., Richman R., Wu Z., Piwnica-Worms H., Elledge S.J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science. 277:1997;1497-1501.
15. Matsuoka S., Huang M., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science. 282:1998;1893-1897.
16. Ahn J.Y., Schwarz J.K., Piwnica-Worms H., Canman C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60:2000;5934-5936.
17. Chaturvedi P., Eng W.K., Zhu Y., Mattern M.R., Mishra R., Hurle M.R., Zhang X., Annan R.S., Lu Q., Faucette L.F., Scott G.F., Li X., Carr S.A., Johnson R.K., Winkler J.D., Zhou B.B.S. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene. 18:1999;4047-4054.
18. Hunter T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell. 83:1995;1-4.
19. Nakamura Y. ATM: the p53 booster. Nat. Med. 4:1998;1231-1232.
20. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
21. cdc2 and its companion cyclin-dependent kinases. Trends Cell Biol. 3:1993;296-301.
22. Tchou W.W., Rom W.N., Tchou-Wong K.M. Novel form of p21(WAF1/CIP1/SDII) protein in phorbol ester-induced G2/M arrest. J. Biol. Chem. 271:1996;29556-29560.
23. Juan H.F., Lin J.Y., Chang W.H., Wu C.Y., Pan T.L., Tseng M.J., Khoo K.H., Chen S.T. Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis. 23:2002;2490-2504.
24. Ye R., Bodero A., Zhou B.B., Khanna K.K., Lavin M.F., Lees-Miller S.P. The plant isoflavonoid genistein activates p53 and Chk2 in an ATM-dependent manner. J. Biol. Chem. 276:2001;4828-4833.
25. Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., Taya Y., Karnitz L.M., Abraham R.T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:1999;4375-4382.
26. Blasina A., Price B.D., Turenne G.A., McGowan C.H. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9:1999;1135-1138.
27. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor A.M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
28. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281:1998;1674-1677.
29. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679.
30. Chan D.W., Son S.C., Block W., Ye R., Douglas P., Goodarzi A.A., Pelley J., Khanna K.K., Taya Y., Lavin M.F., Less-Miller S.P. Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase. J. Biol. Chem. 275:2000;7803-7810.
31. Darbon J.M., Penary M., Escalas N., Casagrande F., Goubin-Gramatica F., Baudouin C., Ducommun B. Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells. J. Biol. Chem. 275:2000;15363-15369.
32. Lees-Miller S.P., Sakaguchi K., Ullrich S.J., Appella E., Anderson C.W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell Biol. 12:1992;5041-5049.
33. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10389-10394.
34. Hartley K.O., Gell D., Smith G.C.M., Zhang H., Divecha N., Connelly M.A., Admon A., Lees-Miller S.P., Anderson C.W., Jackson S.P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell. 82:1995;849-856.
35. EI-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., Vogelsein B. WAF1/ CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
36. Barboule N., Lafon C., Chadebech P., Vidal S., Valette A. Involvement of p21 in the PKC-induced regulation of G2/M cell cycle transition. FEBS Lett. 444:1999;32-37.
37. Donovan F.M., Pike C.J., Cotman C.W., Cunningham D.D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17:1997;5316-5326.
38. Chinery R., Brockman J.A., Peeler M.O., Shyr Y., Beauchamp R.D., Coffey R.J. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF/CIP1 via C/EBPβ Nat. Med. 3:1997;1233-1241.
39. Leach S.D., Scatena C.D., Keefer C.J., Goodman H.A., Song S.Y., Yang L., Pietenpol J.A. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res. 58:1998;3231-3236.
40. Suda M., Yamada S., Toda T., Miyakawa T., Hirata D. Regulation of Wee1 kinase in response to protein synthesis inhibition. FEBS Lett. 486:2000;305-309.
41. Birt D.F., Hendrich S., Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 90:2001;157-177.
42. Frey R.S., Li J., Singletary K.W. Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21 waf/cip1, p27kid1, and Cdc25C expression. Biochem. Pharmacol. 61:2001;979-989.
43. McIntyre B.S., Sylvester P.W. Genistein and erbstatin inhibition of normal mammary epithelial cell proliferation is associated with EGF-receptor down-regulation. Cell Prolif. 31:1998;35-46.
44. Peterson T., Coward L., Kirk M., Falany C., Barnes S. The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis. 17:1996;1861-1869.
45. Flatt P.M., Pietenpol J.A. Mechanism of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery. Drug Metab. Rev. 32:2000;283-305.
46. Rao C.V., Wang C.-X., Simi B., Lubet R., Kelloff G., Steele V., Reddy B.S. Enhancement of experimental colon cancer by genistein. Cancer Res. 57:1997;3717-3722.
47. Ju Y.H., Doerge D.R., Allred K.F., Allred C.D., Helferich W.G. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res. 62:2002;2474-2477.
48. Ju Y.H., Allred C.D., Allred K.F., Karko K.L., Doerge D.R., Helferich W.G. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131:2001;2957-2962.